• June 3-6, 2024
  • San Diego Convention Center, California

Sessions

Loading

Strengthening of the Clinical Trials Environment in Europe Under the Accelerating Clinical Trials (ACT EU) Initiative

Tuesday, June 04, 2024
Breakout Session
Clinical Trials Innovations
31C
ACT EU focuses on optimizing the European clinical trials environment, strengthening clinical trials that provide decisional evidence, delivering excellent, coordinated scientific advice, and engaging all stakeholders to proactively deliver inclusive patient-oriented medicines. The EU regulatory network under Accelerating Clinical Trials in the EU (ACT EU) is leading the transformation initiative with innovation and modernization of the environment facilitating planning, initiation, design, and conduct of clinical trials. The aim is to further develop the EU as a focal point for clinical research, promote the development of high-quality, safe and effective medicines, and better integrate clinical research in the European health system. ACT EU will also ensure a unified EU position on clinical trials in strategic matters at international level and build capacity in drug development and regulatory science.
Speakers
Laura Pioppo
ACT EU Programme manager
European Medicines Agency (EMA)
Claire Skentelbery
Director General
EuropaBio
Back to Session List

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS